ArticleBMC cancer2025

Real-world short-term outcomes and treatment regimen comparisons in patients with metastatic renal cell carcinoma treated with first-line immune combinations.

Masato Kikuta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.